M. Erman Et Al. , "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer," CANCER INVESTIGATION , vol.23, no.3, pp.215-221, 2005
Erman, M. Et Al. 2005. A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer. CANCER INVESTIGATION , vol.23, no.3 , 215-221.
Erman, M., Baltali, E., Karaoglu, A., Abali, H., Engin, H., Ozisik, Y., ... Guler, N.(2005). A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer. CANCER INVESTIGATION , vol.23, no.3, 215-221.
Erman, M Et Al. "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer," CANCER INVESTIGATION , vol.23, no.3, 215-221, 2005
Erman, M Et Al. "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer." CANCER INVESTIGATION , vol.23, no.3, pp.215-221, 2005
Erman, M. Et Al. (2005) . "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer." CANCER INVESTIGATION , vol.23, no.3, pp.215-221.
@article{article, author={M Erman Et Al. }, title={A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer}, journal={CANCER INVESTIGATION}, year=2005, pages={215-221} }